Analysis and clinical correlation of genetic variation in cytomegalovirus

Transplant Infectious Disease

Volumn 14, Issue 2, 2012, Pages 132-140

  Lisboa, L F ^a   Tong, Y ^a   Kumar, D ^a   Pang, X L ^a   Asberg A ^b   Hartmann, A ^b   Rollag, H ^c   Jardine, A G ^d   Pescovitz, M D ^e   Humar, A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Cytomegalovirus; Glycoprotein N; Immediate early 1 protein; Organ transplantation; Polymorphisms

Indexed keywords

GLYCOPROTEIN N; IMMEDIATE EARLY 1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CYTOMEGALOVIRUS INFECTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; ORGAN TRANSPLANTATION; VIRAL LOAD; WORLD HEALTH;

EID: 84859867365     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00685.x     Document Type: Article

References (28)

1. Rubin RH. Importance of CMV in the transplant population. Transpl Infect Dis 1999; 1 (Suppl 1): 3-7.
2. Paya CV. Indirect effects of CMV in the solid organ transplant patient. Transpl Infect Dis 1999; 1 (Suppl 1): 8-12.
3. Manuel O, Asberg A, Pang X, et al. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009; 49 (8): 1160-1166.
4. Humar A, Kumar D, Gilbert C, Boivin G. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003; 188 (4): 581-584.
5. Xia CS, Zhang Z. Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients. Arch Virol 2011; 156 (1): 17-23.
6. Wu X, Wang Y, Xu Y, et al. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China. Biol Blood Marrow Transplant 2010; 16 (5): 647-652.
7. Woo PC, Lo CY, Lo SK, et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 1997; 4 (5): 515-518.
8. Roubalova K, Strunecky O, Zufanova S, Prochazka B, Vitek A. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome]. Epidemiol Mikrobiol Imunol 2010; 59 (2): 92-99.
9. Rossini G, Pignatelli S, Dal Monte P, et al. Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. Microbes Infect 2005; 7 (5-6): 890-896.
10. Pacsa AS, Essa S, Voevodin A, et al. Correlation between CMV genotypes, multiple infections with herpesviruses (HHV-6, 7) and development of CMV disease in kidney recipients in Kuwait. FEMS Immunol Med Microbiol 2003; 35 (2): 125-130.
11. Nogueira E, Ozaki KS, Tomiyama H, Camara NO, Granato CF. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients. Int Immunopharmacol 2009; 9 (1): 26-31.
12. Gorzer I, Kerschner H, Jaksch P, et al. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol 2008; 80 (8): 1405-1414.
13. Shimamura M, Mach M, Britt WJ. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response. J Virol 2006; 80 (9): 4591-4600.
14. Puchhammer-Stockl E, Gorzer I, Zoufaly A, et al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 2006; 81 (2): 187-194.
15. Kern F, Surel IP, Faulhaber N, et al. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol 1999; 73 (10): 8179-8184.
16. Lacey SF, Martinez J, Gallez-Hawkins G, et al. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients. J Infect Dis 2005; 191 (6): 977-984.
17. Simon CO, Holtappels R, Tervo HM, et al. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 2006; 80 (21): 10436-10456.
18. Bunde T, Kirchner A, Hoffmeister B, et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005; 201 (7): 1031-1036.
19. Asberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7 (9): 2106-2113.
20. Lisboa LF, Asberg A, Kumar D, et al. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011; 91 (2): 231-236.
21. Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002; 186 (6): 829-833.
22. Pignatelli S, Dal Monte P, Rossini G, et al. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 2003; 84 (Pt 3): 647-655.
23. Pignatelli S, Dal Monte P, Landini MP. gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol 2001; 82 (Pt 11): 2777-2784.
24. Bates M, Monze M, Bima H, et al. High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology 2008; 382 (1): 28-36.
25. Zweygberg Wirgart B, Brytting M, Linde A, Wahren B, Grillner L. Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol 1998; 36 (12): 3662-3669.
26. Retiere C, Imbert BM, David G, Courcoux P, Hallet MM. A polymorphism in the major immediate-early gene delineates groups among cytomegalovirus clinical isolates. Virus Res 1998; 57 (1): 43-51.
27. Pignatelli S, Lazzarotto T, Gatto MR, et al. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis 2010; 51 (1): 33-41.
28. Gorzer I, Guelly C, Trajanoski S, Puchhammer-Stockl E. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol 2010; 84 (14): 7195-7203.